SavedAdd your journal

Journals / International Journal of Health Services Research and Policy / 2022 / Cilt: 7 - Sayı: 2

THE EFFECT OF ANXIETY LEVELS OF TYPE 2 DIABETES MELLITUS PATIENTS ON THEIR TREATMENT ADHERENCE IN THE COVID-19 PANDEMIC PERIOD

Alev YILDIRIM KESKİN
Sibel ŞENTÜRK
Zeynep Büşra TEKE
Pages
112–126
Publication Date
2022-08-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a negative significant relationship between the MMAS-8 and CAS scores of the patients (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study was conducted to investigate the effects of the anxiety levels of Diabetes Mellitus (DM) patients on their treatment adherence in the COVID-19 pandemic period.
📊
Key Findings & Data:The sample of this descriptive and cross-sectional study consisted of 313 DM patients who presented to the internal medicine outpatient clinic between 01.01.2021 and 01.02.2021.
💡
Conclusion & Impact:There was a negative significant relationship between the MMAS-8 and CAS scores of the patients (p
🔬Design:Research Article
📍Scope:2021 Verileri
⚙️Variables:COVID-19 · Diabetes Mellitus · Type 2

Abstract

This study was conducted to investigate the effects of the anxiety levels of Diabetes Mellitus (DM) patients on their treatment adherence in the COVID-19 pandemic period. The sample of this descriptive and cross-sectional study consisted of 313 DM patients who presented to the internal medicine outpatient clinic between 01.01.2021 and 01.02.2021. The data were collected using a Personal Information Form, the Coronavirus Anxiety Scale (CAS), and the Morisky Medication Adherence Scale (MMAS-8). Descriptive statistics, Mann-Whitney U test, Kruskal-Wallis test and Spearman’s correlation test were used to analyze the data. The mean CAS score of the DM patients was 7.89±3.87, while their mean total MMAS-8 score was 4.06±1.56. It was determined that the patients who were using oral antidiabetic medications, those adhering to their medication and diet treatment, and those who were not COVID-19 had higher levels of anxiety. There was a negative significant relationship between the MMAS-8 and CAS scores of the patients (p

🔖

Cite This Article

KESKİN, A. Y., ŞENTÜRK, S., TEKE, Z. B. (2022). THE EFFECT OF ANXIETY LEVELS OF TYPE 2 DIABETES MELLITUS PATIENTS ON THEIR TREATMENT ADHERENCE IN THE COVID-19 PANDEMIC PERIOD. International Journal of Health Services Research and Policy, Cilt: 7 - Sayı: 2, 112–126. https://ajindex.com/articles/767376

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. WHO., COVID-19 weekly surveillance report. https://www.euro.who.int/en/health-topics/ health-emergencies/coronavirus-covid-19/weekly-surveillance-report 2020, Acces Date: 12.02.2021
  2. Ministry of Health (HM). https://covid19.saglik.gov.tr/.Access Date: 28.12.2021
  3. Mechi, A., Al-Khalidi, R., Al-Darraji, et al., "Long-term persistent symptoms of COVID-19 infection in patients with diabetes mellitus", Internal Journal of Diabetes in Developing Countries, 24, 1-4, 2021.
  4. Tao, L., Gao, Q., Liu, K., Dong, et al., "Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic", Diabetes Research and Clinical Practice, 170, 108514, 2020.
  5. Gupta K.S., Lakshmi, P.V.M., Kaur, M., Rastogi, A., "Role of self care in covid 19 pandemic for people living with comorbidities of diabetes and hypertension", Family Medicine and Primary Care, 30, 9(11), 5495-501, 2020. https://doi.org/ 10.4103/jfmpc.jfmpc_1684_20
  6. Ghosh, A., Arora, B., Gupta, R., et al., "Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north ındia. Diabetes Metabolic Syndrome: Clincal Research & Reviews", 14(5), 917-920, 2020.
  7. Dennis, J.M., Mateen, B.A., Sonabend, R., et al., Type 2 diabetes and COVID-19-related mortality in the critical care setting: a national cohort study in england. Diabetes Care, 44(1), 50–7, 2021. https://doi.org/ 10.2337/dc20-1444
  8. Corrao, S., Pinelli, K., Vacca, M., et al., "Type 2 diabetes mellitus and COVID-19: a narrative review", Front Endocrinol (Lausanne). 12, 609470, 2021.
  9. International diabetes federation (IDF) diabetes atlas –sixth edition, available at. http:/www. diabetesatlas. org. (Access 20 December 2021)
  10. Çelik, G.S., Diabetes mellitus and care management (chapter: 7.3), internal medicine nursing book with case scenarios (Ed. Özer S), Istanbul Medicine Bookstore, 1st Edition, pp.285-303, 2019
  11. Young-Hyman, D., Groot, M. de, Hill-Briggs, F., et al., "Psychosocial care for people with diabetes: a position statement of the American Diabetes Association", Diabetes Care, 39, 2126–2140, 2016.
  12. Koç, E.M., "Investigation of quality of life and associated